1. Home
  2. MLKN vs CTMX Comparison

MLKN vs CTMX Comparison

Compare MLKN & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$14.58

Market Cap

1.0B

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.62

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLKN
CTMX
Founded
1905
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
977.1M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
MLKN
CTMX
Price
$14.58
$3.62
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$12.10
AVG Volume (30 Days)
621.2K
2.9M
Earning Date
03-25-2026
05-08-2026
Dividend Yield
4.71%
N/A
EPS Growth
N/A
N/A
EPS
0.98
N/A
Revenue
$3,669,900,000.00
$76,201,000.00
Revenue This Year
$5.94
N/A
Revenue Next Year
$3.78
$7.61
P/E Ratio
$15.23
$22.58
Revenue Growth
1.14
N/A
52 Week Low
$13.77
$1.72
52 Week High
$23.18
$8.21

Technical Indicators

Market Signals
Indicator
MLKN
CTMX
Relative Strength Index (RSI) 34.17 30.72
Support Level $13.81 $3.39
Resistance Level $16.34 $3.91
Average True Range (ATR) 0.60 0.21
MACD -0.15 -0.04
Stochastic Oscillator 0.82 5.63

Price Performance

Historical Comparison
MLKN
CTMX

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: